From: HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
Adverse Event | Toxicity Criteria Grade 3 or 4 | Raltegravir n = 281 | Efavirenz n = 282 |
---|---|---|---|
Total bilirubin | > 2.5 × ULN | 2 (0.7) | 0 (0.0) |
Alkaline phosphatase | > 5 × ULN | 0 (0.0) | 2 (0.8) |
AST | > 5 × ULN | 6 (2.1) | 5 (1.8) |
ALT | > 5 × ULN | 5 (1.8) | 6 (2.1) |